Nurses can have a key role to play in the patient journeys for people given chimeric antigen receptor T-cell therapy
Chimeric antigen receptor T-cell therapy, known as CAR-T or CAR T-cell therapy, is a relatively new form of immunotherapy that can be used to treat some cancers. During CAR-T therapy, which became available in the UK in 2018, a person’s immune system cells are collected and reprogrammed to target cancer.
Cancer Nursing Practice. 22, 6, 14-15. doi: 10.7748/cnp.22.6.14.s6
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
